跳至主要内容
临床试验/NCT05197543
NCT05197543Unknown不适用

Biomechanical Rupture Risk Assessment in Management of Patients With Abdominal Aortic Aneurysm in COVID-19 Pandemic

Masaryk University1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2020年3月12日最近更新:
适应症

试验速览

阶段
不适用
入组人数
102
试验地点
1
主要终点
Test the clinical applicability of the BRRA method

研究概览

简要总结

The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponing of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI diagnostic method in a quasi-prospective observational patient cohort study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • presence of asymptomatic abdominal aortic aneurysm (AAA)
  • regular CT angiography scans available

排除标准

  • rupture of AAA

结局指标

主要结局

Test the clinical applicability of the BRRA method

时间窗: 21 months

Identify the number of number of false positive and false negative cases assessed by BRRA method according to clinical data and compare these data to control group where the decision making process was based only on maximal diameter of AAA

次要结局

  • Reduction of time required for AAA assessment(21 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luboš Kubíček

Principal Invastigator

Masaryk University

研究点 (1)

Loading locations...

相似试验